Torrent Pharma Seeks CCI Approval for Rs 195 Billion JB Chemicals Deal
ECONOMY & POLICY

Torrent Pharma Seeks CCI Approval for Rs 195 Billion JB Chemicals Deal

Ahmedabad-based Torrent Pharmaceuticals has sought clearance from the Competition Commission of India (CCI) to acquire a majority stake in J B Chemicals and Pharmaceuticals in a Rs 195 billion deal.
Upon completion, Torrent Pharmaceuticals will become India’s second most valuable pharmaceutical company.
The move follows Torrent’s June announcement to acquire a majority stake in J B Chemicals for Rs 195 billion.
“The proposed combination pertains to the acquisition of shareholding by Torrent Pharmaceuticals Ltd in J B Chemicals & Pharmaceuticals Ltd, followed by the merger of the target with the acquirer,” stated a notice filed with the CCI.
Torrent Pharmaceuticals, the flagship company of the Torrent Group, manufactures and sells pharmaceutical formulations across multiple therapeutic segments.
J B Chemicals & Pharmaceuticals is involved in manufacturing and marketing a wide range of formulations and active pharmaceutical ingredients (APIs), and also provides contract development and manufacturing organisation (CDMO) services.
The companies acknowledged horizontal overlaps in certain markets related to the manufacture and sale of pharmaceutical formulations in India.
In June, Torrent agreed to acquire 46.39 per cent stake from promoters Tau Investment Holdings Pte Ltd, an affiliate of global investment firm KKR, for around Rs 119.17 billion. Additionally, it will buy a further 2.80 per cent stake from certain JB Chemicals employees at Rs 1,600 per share, amounting to Rs 7.19 billion.
Following these purchases, Torrent will launch an open offer to acquire 26 per cent from the open market at Rs 1,639.18 per share, totalling Rs 68.43 billion, as per stock exchange norms.
This will be the second largest deal in the Indian pharmaceutical sector, after Sun Pharmaceutical Industries’ 2015 acquisition of Ranbaxy Laboratories. After the share purchase, JB Chemicals will merge into Torrent.
KKR had initially acquired a 65 per cent stake in JB Chemicals in 2020. Earlier this year, in March, KKR divested 5.8 per cent of its stake in JB Chemicals for Rs 14.6 billion via open market transactions.
Founded in 1976, JB Chemicals produces pharmaceuticals in areas including gastroenterology, dermatology and diabetes.
Torrent Pharmaceuticals, with annual revenues exceeding Rs 115 billion, is the flagship company of the Torrent Group, which generates group revenues of Rs 450 billion.
In a comparable major transaction, Sun Pharma announced in April 2014 its plan to acquire rival Ranbaxy for USD 4 billion in an all-stock deal, including USD 800 million in debt. The merger was completed after receiving regulatory approvals in March 2015.
Another significant recent deal saw Mankind Pharma acquire Bharat Serums and Vaccines last year for Rs 138 billion. 

Ahmedabad-based Torrent Pharmaceuticals has sought clearance from the Competition Commission of India (CCI) to acquire a majority stake in J B Chemicals and Pharmaceuticals in a Rs 195 billion deal.Upon completion, Torrent Pharmaceuticals will become India’s second most valuable pharmaceutical company.The move follows Torrent’s June announcement to acquire a majority stake in J B Chemicals for Rs 195 billion.“The proposed combination pertains to the acquisition of shareholding by Torrent Pharmaceuticals Ltd in J B Chemicals & Pharmaceuticals Ltd, followed by the merger of the target with the acquirer,” stated a notice filed with the CCI.Torrent Pharmaceuticals, the flagship company of the Torrent Group, manufactures and sells pharmaceutical formulations across multiple therapeutic segments.J B Chemicals & Pharmaceuticals is involved in manufacturing and marketing a wide range of formulations and active pharmaceutical ingredients (APIs), and also provides contract development and manufacturing organisation (CDMO) services.The companies acknowledged horizontal overlaps in certain markets related to the manufacture and sale of pharmaceutical formulations in India.In June, Torrent agreed to acquire 46.39 per cent stake from promoters Tau Investment Holdings Pte Ltd, an affiliate of global investment firm KKR, for around Rs 119.17 billion. Additionally, it will buy a further 2.80 per cent stake from certain JB Chemicals employees at Rs 1,600 per share, amounting to Rs 7.19 billion.Following these purchases, Torrent will launch an open offer to acquire 26 per cent from the open market at Rs 1,639.18 per share, totalling Rs 68.43 billion, as per stock exchange norms.This will be the second largest deal in the Indian pharmaceutical sector, after Sun Pharmaceutical Industries’ 2015 acquisition of Ranbaxy Laboratories. After the share purchase, JB Chemicals will merge into Torrent.KKR had initially acquired a 65 per cent stake in JB Chemicals in 2020. Earlier this year, in March, KKR divested 5.8 per cent of its stake in JB Chemicals for Rs 14.6 billion via open market transactions.Founded in 1976, JB Chemicals produces pharmaceuticals in areas including gastroenterology, dermatology and diabetes.Torrent Pharmaceuticals, with annual revenues exceeding Rs 115 billion, is the flagship company of the Torrent Group, which generates group revenues of Rs 450 billion.In a comparable major transaction, Sun Pharma announced in April 2014 its plan to acquire rival Ranbaxy for USD 4 billion in an all-stock deal, including USD 800 million in debt. The merger was completed after receiving regulatory approvals in March 2015.Another significant recent deal saw Mankind Pharma acquire Bharat Serums and Vaccines last year for Rs 138 billion. 

Next Story
Technology

AI-Enabled Workflows Lift Profitability and Productivity

Organisations modernising frontline workflows with artificial intelligence, automation and real-time data are reporting stronger financial performance, higher productivity and improved employee engagement, according to a global study by Zebra Technologies and Oxford Economics.The research covered 1,000 senior leaders across retail, manufacturing, transportation and logistics in the US, Mexico, the UK, Germany, India, Japan, Australia and New Zealand.In transportation and logistics, 54 per cent of companies that improved picking and packing operations reported faster operational performance, wh..

Next Story
Real Estate

India Leads Global AI Readiness but Implementation Lags

Indian companies lead global averages across all eight artificial intelligence readiness indicators tracked by JLL, but only 19 per cent have started making changes to their workplaces, according to the JLL 2026 Future of Work Survey.The study found that 77 per cent of Indian business leaders expect AI to change their office requirements, creating a 58-percentage-point gap between awareness and implementation. The survey covered more than 2,200 CEOs, CFOs and real estate leaders across 21 countries during the first quarter of 2026.Despite concerns over automation, 58 per cent of Indian leaders..

Next Story
Equipment

Three WOLFF Cranes Build Riyadh Cable-Stayed Bridges

Three WOLFF 180 B luffing jib cranes are supporting the construction of two cable-stayed bridges alongside the existing Wadi Laban Bridge in Riyadh, Saudi Arabia. The project is being developed for the Royal Commission for Riyadh City and executed by the ICRC joint venture comprising IC Ictas and Al Rashid Trading & Contracting Company.The cranes are handling lifting operations including formwork, reinforcement, concrete placement, work platforms, surveying equipment and other construction materials. Each crane is fitted with a 40 m jib, reaches a hook height of 157 m and offers a maximum ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement